创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Advances in Antiretroviral Therapy and Drug Development for AIDS
YAO Cheng, ZHU Panpan, XIE Dong
2018, 42(2): 84-98.
Abstract PDF
Advances in Research on Anti-HIV Natural Products
HUANG Jie
2018, 42(2): 99-112.
Abstract PDF
Research Progress in HIV Entry Inhibitors
ZWANG Fanwen, LAO Xingzhen, ZHENG Heng, GU Juefen
2018, 42(2): 113-121.
Abstract PDF
Advances in Research on HIV-1 Gene Therapy
ZHENG Heng
2018, 42(2): 122-128.
Abstract PDF
Advances in Clinical Research of Matrix Metalloproteinase Inhibitors as Anticancer Agents
HAN Yanzhen, XUE Jianpeng, HU Jialiang, XU Hanmei
2018, 42(2): 129-137.
Abstract PDF
2018 Outlook: A New Era for Innovative Drug R & D of China's Pharmaceutical Industry
XU Lili, SHAO Liming
2018, 42(2): 138-140.
Abstract PDF
Strategies of Core Value Assessment for Innovative Pharmaceutical Projects
WU Hongzhong, REN Chunyan
2018, 42(2): 141-147.
Abstract PDF
Summary and Review of New Drugs Approved by FDA, EMA and PMDA in 2017 (Ⅱ)
WEI Lijun
2018, 42(2): 148-157.
Abstract PDF
An Overview of New Drugs Approved in the US, EU and Japan in January 2018
SUN Yousong
2018, 42(2): 158-160.
Abstract PDF